v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
shares in Millions, $ in Millions
Total
Adjustments
Common Stock Shares
Treasury Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Retained Earnings
Adjustments
Beginning balance (in shares) at Dec. 31, 2023     1,072          
Beginning balance at Dec. 31, 2023 $ 21,051     $ (21,045) $ 19,642 $ (746) $ 23,200  
Increase (Decrease) in Stockholders' Equity                
Net income 888           888  
Foreign CTA, net (161)         (161)    
Tax (expense) benefit on foreign CTA, net 18         18    
Net investment hedges CTA gains, net 99         99    
Tax expense on net investment hedges CTA gains, net (23)         (23)    
Unrealized (losses) gains on cash flow hedges, net 96         96    
Tax benefit (expense) on unrealized losses on cash flow hedges, net (5)         (5)    
Unrealized (losses) gains on available-for-sale debt securities, net 83         83    
Tax benefit (expense) on unrealized (losses) gains on available-for-sale debt securities, net (20)         (20)    
Common stock and stock-based awards issued, net of shares withheld for employee taxes (in shares)     6          
Common stock and stock-based awards issued, net of shares withheld for employee taxes (193)       (193)      
Common stock repurchased (in shares)     (25)          
Common stock repurchased (1,511)     (1,511)        
Treasury stock reissuance 4     4        
Stock-based compensation 376       376      
Ending balance (in shares) at Mar. 31, 2024     1,053          
Ending balance at Mar. 31, 2024 20,702     (22,552) 19,825 (659) 24,088  
Beginning balance (in shares) at Dec. 31, 2023     1,072          
Beginning balance at Dec. 31, 2023 21,051     (21,045) 19,642 (746) 23,200  
Increase (Decrease) in Stockholders' Equity                
Net income 2,016              
Foreign CTA, net (287)              
Tax (expense) benefit on foreign CTA, net 19              
Net investment hedges CTA gains, net 199              
Tax expense on net investment hedges CTA gains, net (47)              
Unrealized (losses) gains on cash flow hedges, net 99              
Tax benefit (expense) on unrealized losses on cash flow hedges, net (5)              
Unrealized (losses) gains on available-for-sale debt securities, net 98              
Tax benefit (expense) on unrealized (losses) gains on available-for-sale debt securities, net (23)              
Ending balance (in shares) at Jun. 30, 2024     1,032          
Ending balance at Jun. 30, 2024 20,622     (24,064) 20,163 (693) 25,216  
Beginning balance (in shares) at Mar. 31, 2024     1,053          
Beginning balance at Mar. 31, 2024 20,702     (22,552) 19,825 (659) 24,088  
Increase (Decrease) in Stockholders' Equity                
Net income 1,128           1,128  
Foreign CTA, net (126)         (126)    
Tax (expense) benefit on foreign CTA, net 1         1    
Net investment hedges CTA gains, net 100         100    
Tax expense on net investment hedges CTA gains, net (24)         (24)    
Unrealized (losses) gains on cash flow hedges, net 3         3    
Tax benefit (expense) on unrealized losses on cash flow hedges, net 0              
Unrealized (losses) gains on available-for-sale debt securities, net 15         15    
Tax benefit (expense) on unrealized (losses) gains on available-for-sale debt securities, net (3)         (3)    
Common stock and stock-based awards issued, net of shares withheld for employee taxes (in shares)     3          
Common stock and stock-based awards issued, net of shares withheld for employee taxes 13       13      
Common stock repurchased (in shares)     (24)          
Common stock repurchased (1,516)     (1,516)        
Treasury stock reissuance 4     4        
Stock-based compensation 325       325      
Ending balance (in shares) at Jun. 30, 2024     1,032          
Ending balance at Jun. 30, 2024 $ 20,622     (24,064) 20,163 (693) 25,216  
Beginning balance (in shares) at Dec. 31, 2024 993   993          
Beginning balance at Dec. 31, 2024 $ 20,417 $ 20   (27,085) 20,705 (550) 27,347 $ 20
Increase (Decrease) in Stockholders' Equity                
Net income 1,287           1,287  
Foreign CTA, net 127         127    
Tax (expense) benefit on foreign CTA, net (25)         (25)    
Unrealized (losses) gains on cash flow hedges, net (176)         (176)    
Tax benefit (expense) on unrealized losses on cash flow hedges, net 9         9    
Unrealized (losses) gains on available-for-sale debt securities, net (9)         (9)    
Tax benefit (expense) on unrealized (losses) gains on available-for-sale debt securities, net 2         2    
Common stock and stock-based awards issued, net of shares withheld for employee taxes (in shares)     5          
Common stock and stock-based awards issued, net of shares withheld for employee taxes (171)       (171)      
Common stock repurchased (in shares)     (19)          
Common stock repurchased (1,512)     (1,512)        
Stock-based compensation 285       285      
Ending balance (in shares) at Mar. 31, 2025     979          
Ending balance at Mar. 31, 2025 $ 20,254     (28,597) 20,819 (622) 28,654  
Beginning balance (in shares) at Dec. 31, 2024 993   993          
Beginning balance at Dec. 31, 2024 $ 20,417 $ 20   (27,085) 20,705 (550) 27,347 $ 20
Increase (Decrease) in Stockholders' Equity                
Net income 2,548              
Foreign CTA, net 289              
Tax (expense) benefit on foreign CTA, net (59)              
Net investment hedges CTA gains, net 0              
Tax expense on net investment hedges CTA gains, net 0              
Unrealized (losses) gains on cash flow hedges, net (424)              
Tax benefit (expense) on unrealized losses on cash flow hedges, net 20              
Unrealized (losses) gains on available-for-sale debt securities, net (20)              
Tax benefit (expense) on unrealized (losses) gains on available-for-sale debt securities, net $ 5              
Ending balance (in shares) at Jun. 30, 2025 960   960          
Ending balance at Jun. 30, 2025 $ 20,201     (30,111) 21,136 (739) 29,915  
Beginning balance (in shares) at Mar. 31, 2025     979          
Beginning balance at Mar. 31, 2025 20,254     (28,597) 20,819 (622) 28,654  
Increase (Decrease) in Stockholders' Equity                
Net income 1,261           1,261  
Foreign CTA, net 162         162    
Tax (expense) benefit on foreign CTA, net (34)         (34)    
Net investment hedges CTA gains, net 0              
Tax expense on net investment hedges CTA gains, net 0              
Unrealized (losses) gains on cash flow hedges, net (248)         (248)    
Tax benefit (expense) on unrealized losses on cash flow hedges, net 11         11    
Unrealized (losses) gains on available-for-sale debt securities, net (11)         (11)    
Tax benefit (expense) on unrealized (losses) gains on available-for-sale debt securities, net 3         3    
Common stock and stock-based awards issued, net of shares withheld for employee taxes (in shares)     3          
Common stock and stock-based awards issued, net of shares withheld for employee taxes (2)       (2)      
Common stock repurchased (in shares)     (22)          
Common stock repurchased (1,514)     (1,514)        
Stock-based compensation $ 319       319      
Ending balance (in shares) at Jun. 30, 2025 960   960          
Ending balance at Jun. 30, 2025 $ 20,201     $ (30,111) $ 21,136 $ (739) $ 29,915